Is selective 5-HT1F receptor agonism an entity apart from that of the triptans in antimigraine therapy?

Eloísa Rubio-Beltrán, Alejandro Labastida-Ramírez, Carlos M Villalón, Antoinette MaassenVanDenBrink

Research output: Contribution to journal › Review article › peer-review

Fingerprint

Dive into the research topics of 'Is selective 5-HT1F receptor agonism an entity apart from that of the triptans in antimigraine therapy?'. Together they form a unique fingerprint.

Medicine and Dentistry

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science